Tefron Ltd.
TFRFF
$7.34
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 76.38M | 78.47M | 75.58M | 61.83M | 61.23M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 76.38M | 78.47M | 75.58M | 61.83M | 61.23M |
| Cost of Revenue | 57.98M | 61.37M | 57.67M | 48.12M | 46.76M |
| Gross Profit | 18.41M | 17.10M | 17.91M | 13.71M | 14.47M |
| SG&A Expenses | 9.77M | 8.55M | 8.75M | 7.74M | 7.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.57M | 71.69M | 68.23M | 57.39M | 55.51M |
| Operating Income | 6.81M | 6.78M | 7.35M | 4.44M | 5.72M |
| Income Before Tax | 5.69M | 5.70M | 6.19M | 3.17M | 4.44M |
| Income Tax Expenses | 1.32M | 1.18M | 1.88M | 424.00K | 1.10M |
| Earnings from Continuing Operations | 4.37M | 4.52M | 4.31M | 2.75M | 3.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.37M | 4.52M | 4.31M | 2.75M | 3.34M |
| EBIT | 6.81M | 6.78M | 7.35M | 4.44M | 5.72M |
| EBITDA | 8.87M | 8.82M | 9.29M | 5.80M | 7.54M |
| EPS Basic | 0.35 | 0.35 | 0.35 | 0.23 | 0.27 |
| Normalized Basic EPS | 0.29 | 0.28 | 0.31 | 0.16 | 0.22 |
| EPS Diluted | 0.32 | 0.33 | 0.33 | 0.21 | 0.26 |
| Normalized Diluted EPS | 0.26 | 0.26 | 0.30 | 0.15 | 0.22 |
| Average Basic Shares Outstanding | 12.49M | 12.90M | 12.30M | 12.14M | 12.37M |
| Average Diluted Shares Outstanding | 13.66M | 13.68M | 13.05M | 13.35M | 12.85M |
| Dividend Per Share | -- | -- | -- | 0.16 | -- |
| Payout Ratio | -- | 44.18% | -- | -- | -- |